Mettler-Toledo International Inc.
General ticker "MTD" information:
- Sector: Health Care
- Industry: Medical - Diagnostics & Research
- Capitalization: $25.8B (TTM average)
Mettler-Toledo International Inc. follows the US Stock Market performance with the rate: 72.0%.
Estimated limits based on current volatility of 1.4%: low 1463.28$, high 1504.83$
Factors to consider:
- Company included in S&P500 list
- Total employees count: 17300 (0.0%) as of 2024
- US accounted for 36.9% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Economic downturns and volatility, Cybersecurity threats, Supply chain disruptions, Pandemic risks, Labor/talent shortage/retention
- Price in estimated range
- Earnings for 9 months up through Q3 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [1152.09$, 1602.60$]
- 2025-12-31 to 2026-12-31 estimated range: [1268.73$, 1747.80$]
Financial Metrics affecting the MTD estimates:
- Negative: with PPE of 29.8 at the end of fiscal year the price was high
- Positive: Operating profit margin, % of 29.11 > 18.33
- Negative: Shareholder equity ratio, % of -3.92 <= 19.35
- Positive: Inventory ratio change, % of -1.18 <= -0.76
- Positive: Industry inventory ratio change (median), % of -0.84 <= -0.18
- Positive: Interest expense per share per price, % of 0.29 <= 0.74
- Negative: Operating cash flow per share per price, % of 3.71 <= 6.63
- Positive: Investing cash flow per share per price, % of -0.46 > -0.62
- Negative: negative Industry operating cash flow (median)
Short-term MTD quotes
Long-term MTD plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $3,919.71MM | $3,788.31MM | $3,872.36MM |
| Operating Expenses | $2,793.49MM | $2,708.63MM | $2,745.31MM |
| Operating Income | $1,126.22MM | $1,079.68MM | $1,127.05MM |
| Non-Operating Income | $-55.63MM | $-105.95MM | $-89.83MM |
| Interest Expense | $55.39MM | $77.37MM | $74.63MM |
| R&D Expense | $177.12MM | $185.28MM | $189.36MM |
| Income(Loss) | $1,070.59MM | $973.73MM | $1,037.22MM |
| Taxes | $198.09MM | $184.95MM | $174.08MM |
| Profit(Loss)* | $872.50MM | $788.78MM | $863.14MM |
| Stockholders Equity | $24.79MM | $-149.94MM | $-126.89MM |
| Inventory | $441.69MM | $385.87MM | $342.27MM |
| Assets | $3,492.39MM | $3,355.55MM | $3,240.00MM |
| Operating Cash Flow | $859.07MM | $965.87MM | $968.35MM |
| Capital expenditure | $121.24MM | $105.32MM | $103.90MM |
| Investing Cash Flow | $-139.40MM | $-131.69MM | $-119.46MM |
| Financing Cash Flow | $-716.04MM | $-859.59MM | $-855.98MM |
| Earnings Per Share** | $38.79 | $36.10 | $40.67 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.